(1S,2R,5R,7R,8R)-2,6,6,8-tetramethyltricyclo[5.3.1.01,5]undecan-8-ol

Details

Top
Internal ID 31b070df-b5c0-441e-afb8-1cc508c12dbc
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids > Cedrane and isocedrane sesquiterpenoids
IUPAC Name (1S,2R,5R,7R,8R)-2,6,6,8-tetramethyltricyclo[5.3.1.01,5]undecan-8-ol
SMILES (Canonical) CC1CCC2C13CCC(C(C3)C2(C)C)(C)O
SMILES (Isomeric) C[C@@H]1CC[C@H]2[C@]13CC[C@@]([C@H](C3)C2(C)C)(C)O
InChI InChI=1S/C15H26O/c1-10-5-6-11-13(2,3)12-9-15(10,11)8-7-14(12,4)16/h10-12,16H,5-9H2,1-4H3/t10-,11-,12-,14-,15+/m1/s1
InChI Key SVURIXNDRWRAFU-FWZIUSJTSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H26O
Molecular Weight 222.37 g/mol
Exact Mass 222.198365449 g/mol
Topological Polar Surface Area (TPSA) 20.20 Ų
XlogP 3.90
Atomic LogP (AlogP) 3.61
H-Bond Acceptor 1
H-Bond Donor 1
Rotatable Bonds 0

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (1S,2R,5R,7R,8R)-2,6,6,8-tetramethyltricyclo[5.3.1.01,5]undecan-8-ol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9969 99.69%
Caco-2 + 0.6440 64.40%
Blood Brain Barrier + 0.8500 85.00%
Human oral bioavailability + 0.5429 54.29%
Subcellular localzation Lysosomes 0.6146 61.46%
OATP2B1 inhibitior - 0.8476 84.76%
OATP1B1 inhibitior + 0.9517 95.17%
OATP1B3 inhibitior + 0.9479 94.79%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 0.8750 87.50%
BSEP inhibitior - 0.9380 93.80%
P-glycoprotein inhibitior - 0.9482 94.82%
P-glycoprotein substrate - 0.9278 92.78%
CYP3A4 substrate - 0.5000 50.00%
CYP2C9 substrate + 0.6165 61.65%
CYP2D6 substrate - 0.7496 74.96%
CYP3A4 inhibition - 0.9434 94.34%
CYP2C9 inhibition - 0.7741 77.41%
CYP2C19 inhibition - 0.9005 90.05%
CYP2D6 inhibition - 0.9607 96.07%
CYP1A2 inhibition - 0.6968 69.68%
CYP2C8 inhibition - 0.9045 90.45%
CYP inhibitory promiscuity - 0.9748 97.48%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.8400 84.00%
Carcinogenicity (trinary) Non-required 0.6760 67.60%
Eye corrosion - 0.9002 90.02%
Eye irritation + 0.9403 94.03%
Skin irritation + 0.7040 70.40%
Skin corrosion - 0.9049 90.49%
Ames mutagenesis - 0.8500 85.00%
Human Ether-a-go-go-Related Gene inhibition - 0.6117 61.17%
Micronuclear - 1.0000 100.00%
Hepatotoxicity - 0.5249 52.49%
skin sensitisation + 0.7070 70.70%
Respiratory toxicity - 0.5111 51.11%
Reproductive toxicity + 0.6111 61.11%
Mitochondrial toxicity + 0.5375 53.75%
Nephrotoxicity - 0.7582 75.82%
Acute Oral Toxicity (c) III 0.8222 82.22%
Estrogen receptor binding - 0.6893 68.93%
Androgen receptor binding - 0.7392 73.92%
Thyroid receptor binding - 0.5581 55.81%
Glucocorticoid receptor binding - 0.6390 63.90%
Aromatase binding - 0.6311 63.11%
PPAR gamma - 0.7558 75.58%
Honey bee toxicity - 0.7889 78.89%
Biodegradation - 0.6250 62.50%
Crustacea aquatic toxicity + 0.7500 75.00%
Fish aquatic toxicity + 0.8435 84.35%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL1293235 P02545 Prelamin-A/C 631 nM
Potency
via Super-PRED
CHEMBL1947 P10828 Thyroid hormone receptor beta-1 501.2 nM
Potency
via Super-PRED

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 94.50% 97.25%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 92.22% 96.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 84.13% 100.00%
CHEMBL221 P23219 Cyclooxygenase-1 83.61% 90.17%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 83.40% 91.11%
CHEMBL5608 Q16288 NT-3 growth factor receptor 83.40% 95.89%
CHEMBL4026 P40763 Signal transducer and activator of transcription 3 82.70% 82.69%
CHEMBL3137262 O60341 LSD1/CoREST complex 81.30% 97.09%
CHEMBL4227 P25090 Lipoxin A4 receptor 80.47% 100.00%

Cross-Links

Top
PubChem 7076489
NPASS NPC90670
LOTUS LTS0127073
wikiData Q105262468